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Metabolic and nutrient-sensing pathways play an important role in controlling the efficacy
of effector T cells. Oxygen is a critical regulator of cellular metabolism. However, during
immune responses T cells must function in oxygen-deficient, or hypoxic, environments.
Here, we used high resolution mass spectrometry to investigate how the proteome of
primary murine CD8+ cytotoxic T lymphocytes (CTLs) is reconfigured in response to
hypoxia in vitro. We identified and quantified over 7,600 proteins and discovered that
hypoxia increased the abundance of a selected number of proteins in CTLs. This included
glucose transporters, metabolic enzymes, transcription factors, cytolytic effector
molecules, checkpoint receptors and adhesion molecules. While some of these
proteins may augment the effector functions of CTLs, others may limit their cytotoxicity.
Moreover, we determined that hypoxia could inhibit IL-2-induced proliferation cues and
antigen-induced pro-inflammatory cytokine production in CTLs. These data provide a
comprehensive resource for understanding the magnitude of the CTL response to
hypoxia and emphasise the importance of oxygen-sensing pathways for controlling
CD8+ T cells. Additionally, this study provides new understanding about how hypoxia
may promote the effector function of CTLs, while contributing to their dysfunction in
some contexts.
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CD8+ cytotoxic T lymphocytes (CTLs) are essential adaptive immune cells that destroy pathogen
infected cells and tumour cells. CD8+ T cell differentiation is directed by antigen receptors and
signalling pathways co-ordinated by co-stimulatory receptors, inhibitory receptors and cytokines
(1). Environmentally controlled metabolic signalling pathways are also critical regulators of CTL
differentiation and function (2–4), and as CD8+ T cells respond to immune activation they increase
expression of nutrient transporters, nutrient sensors, and oxygen-sensing molecules (5).
Oxygen (O2), is essential for oxidative phosphorylation, and the energy production required to
sustain metazoan cells (6). However, the oxygen environment that T cells experience in vivo can beorg September 2021 | Volume 12 | Article 7124021
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environments, i.e. a site where there is a deficiency in oxygen
caused by an imbalance between oxygen supply and demand. For
example, lymph node germinal centres (7) and the gut mucosal
barrier of the intestine (8) are relatively hypoxic. Additionally,
viral infections can trigger localised hypoxia in lung tissues
because of damage to alveolar epithelial cells and pulmonary
capillaries (9, 10). An insufficient blood supply due to poor or
damaged vasculature can also contribute to tissue hypoxia: it is
well established that the suboptimal architecture of blood vessels
in tumours contributes to a hypoxic microenvironment (11–13).
Indeed, T cells have been observed within hypoxic areas of some
tumours (14–17).
Studies have examined how changes in oxygen availability
impact on CD8+ T cells. Exposure of CD8+ T cells to hypoxia,
either during the initial priming of naïve T cells or once they had
differentiated into effector CTLs, has been shown to enhance
CD8+ T cell cytolytic capacity (18–23), inhibit T cell proliferation
(18, 22–25), and increase the expression of the IL-2 receptor
alpha chain (IL-2Ra, also known as CD25) (18, 22),
costimulatory receptors (22, 26, 27) and inhibitory checkpoint
molecules (22, 23, 26, 27) on CD8+ T cells. Hypoxic CD8+ T cells
have been reported to increase expression of effector molecules
(26–28) and the production of cytokines such as IL-10 (22, 23)
and Interferon gamma (IFNg) (26, 29, 30). However, in this latter
context there are also some conflicting data that hypoxia
decreases IFNg production (16, 18, 31) by T cells.
One important oxygen-sensing pathway in CTL is mediated
by HIF1 (hypoxia-inducible factor 1) transcriptional complexes
(26–28, 32–34). The expression of the HIF1alpha (HIF1a)
subunit of the HIF1 complex is regulated by the oxygen-
dependent PHD family prolyl hydroxylases (PHD1,2 3) (6, 35,
36). In high oxygen, PHD proteins hydroxylate prolines in
HIF1a targeting it for ubiquitylation mediated by the VHL-
containing ubiquitin ligase complex and subsequent proteasomal
degradation. HIF1a levels are thus lower in CTLs when
environmental oxygen is high but rapidly increase in response
to reduced oxygen availability. Loss of VHL or PHDs is linked to
enhanced effector CD8+ T cell function (27, 32, 33). There are,
however, HIF- independent ways whereby changes in oxygen
availability could impact T cells. CTLs still depend on oxidative
phosphorylation in vivo (37) and PHDs can have substrates
other than HIF1a (38, 39). There are also histone demethylases
which utilize oxygen in their catalytic mechanism to couple
environmental oxygen changes to epigenetic histone
modifications (40–42). Additionally, oxygen control of mRNA
translation (43) and pathways of protein degradation are part of
cellular responses to changing oxygen availability. For example,
CTLs express the cysteine dioxygenase ADO which controls the
oxygen-dependent degradation of proteins via the N-degron
pathway (44). Therefore, hypoxia may reconfigure the
phenotype of T cells at multiple levels.
As hypoxia, and activation of hypoxia-induced gene
expression, has been linked to both promoting and inhibiting
the effector function of CTLs, the objective of this study was to
examine the impact of hypoxia on pure cultures of CTLsFrontiers in Immunology | www.frontiersin.org 2differentiated in vitro. We used mass spectrometry-based
proteomics to perform a high-resolution unbiased analysis of
the proteome of CTLs in normoxia and hypoxia. These data
provide a comprehensive understanding of how hypoxia alters
the proteomic landscape of CTLs and provides new insights
towards reconciling how hypoxia may promote CTL effector
function, yet lead to their dysfunction in different contexts.MATERIALS AND METHODS
Mice
P14 mice have been described previously (45). Female P14 T cell
receptor transgenic mice were used for proteomic studies, and
both male and female mice were used for other experiments. All
mice were bred and maintained in the University of Dundee in
compliance with UK Home Office Animals (Scientific
Procedures) Act 1986 guidelines.
In Vitro Cultures of Cytotoxic
T Lymphocytes (CTLs)
CTLs were generated as described previously (34). Briefly, P14
CD8+ naïve T cells taken from the spleens of mice were activated
by triggering of the T cell receptor (TCR) with 100 ng/ml gp-33
peptide of the Lymphocytic Choriomeningitis Virus (LCMV) for
48 hours in the presence of 20 ng/ml IL-2 (Proleukin, Novartis)
and 2 ng/ml IL-12 (Peprotech) in a humidified incubator with a
gas atmosphere of 18% oxygen and 5% CO2.
After 48 hours, the activated CD8+ cells were removed from
TCR stimulation and were then cultured in RPMI 1640
(ThermoFisher Scientific), with 10% foetal bovine serum (FBS)
(Life Technologies), supplemented with 50 units/ml penicillin-G
(GIBCO), 50 mg/ml streptomycin (GIBCO), 50 mM
b-mercaptoethanol (Sigma-Aldrich) and 20 ng/ml IL-2
(Proleukin, Novartis) in a gas atmosphere of 18% oxygen and
5% CO2. Cells were counted every day, and split to a density of
5×105 cells per ml in RPMI 1640 with 10% FBS, 50 units/ml
pen ic i l l in -G , 50 mg/ml s t r ep tomyc in and 50 mM
b-mercaptoethanol with fresh IL-2 being added at a final
concentration of 20 ng/ml. Samples were considered biological
replicates if CTLs were generated from separate spleens.
For most of this study, we analysed the impact of hypoxia on
CTLs after 24 hours: specifically, for the proteomics analyses,
flow cytometry forward and side scatter analyses, lactate
production, protein synthesis assays, cell cycle analyses and
determination of cytokine production after antigen-receptor
triggering. For all of these experiments, CD8+ T cells were
differentiated in IL-2 for 4 days in a gas atmosphere of 18%
oxygen and 5% CO2 before being subjected to hypoxia as detailed
in “24-hour hypoxia treatments”. For proliferation assays, we
counted cells over 48 hours in hypoxia. To ensure that the cells
were still undergoing exponential growth during the evaluation,
CD8+ T cells were differentiated in IL-2 for 3 days in a gas
atmosphere of 18% oxygen and 5% CO2 before being subjected
to hypoxia as detailed in “48-hour proliferation assays”.September 2021 | Volume 12 | Article 712402
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Cell Counting
For routine culture, and for setting up specific analyses,
suspensions of CD8 T cells in RPMI were taken directly from
the cell cultures and were diluted 1:10 with 1% FBS (v/v) in PBS +
DAPI. FSC and SSC data and DAPI signal were acquired on a
FACSVerse flow cytometer with FACSuite software
(BD Biosciences). Viable cells were determined according to
DAPI staining. The volumetric measurements acquired by the
FACSVerse during sample acquisition were used to determine an
accurate cell count. Data analysis was performed with FlowJo
software (Treestar).
24-Hour Hypoxia Treatments
Following activation and 4 days of differentiation in IL-2, CTLs
were counted and resuspended at a concentration of 3×105 cells
per ml in RPMI 1640 with 10% FBS, 50 units/ml penicillin-G,
50 mg/ml streptomycin, 50 mM b-mercaptoethanol and 20 ng/ml
IL-2. Cells were seeded at 3×105 cells/ml to mitigate for nutrient
deprivation that may occur in hypoxia through a combination of
proliferation, and the upregulation of nutrient transporters such as
GLUT1 and GLUT3. A volume of 8 mls of the cell suspension was
plated per well of a 6 well plate. Cells were rested for 2 hours before
being maintained in a gas atmosphere of 18% oxygen and 5% CO2
or being transferred to an atmosphere of 1% O2 and 5% CO2 in a
Galaxy 48 R incubator (Eppendorf) for 24 hours. After 24 hours,
cells were counted and processed based on the requirements of
individual experiments.
48-Hour Proliferation Assays
For proliferation assays, CTLs that had been generated by
activating naïve CD8+ T cells for 2 days followed by
differentiation in IL-2 for 3 days were counted and split to
3×105 cells per ml in RPMI 1640 (plus 10% FBS, 50 units/ml
penicillin-G, 50 mg/ml streptomycin, 50 mM b-mercaptoethanol)
with 20 ng/ml IL-2. A volume of 8 mls of the cell suspension was
plated per well of a 6 well plate. Cells were either maintained at
18% oxygen + 5% CO2 or transferred to an atmosphere of 1% O2 +
5% CO2 in a Galaxy 48 R incubator (Eppendorf). After 24 hours,
cells were counted to evaluate cell proliferation. Additionally, these
counts were used to split cells, in duplicate plates, to 3×105 cells per
ml with fresh IL-2 being added at a final concentration of 20 ng/ml.
For these experiments, the RPMI was pre-equilibrated to 18% or 1%
oxygen by keeping aliquots of the media in plates in the appropriate
incubators overnight. Cells were counted 24 hours later to generate
the data for the 48 hour time point.
Protein Digestion for Proteomic Samples
Pellets of CTLs prepared as described in “24-hour hypoxia
treatments” were lysed in 400 ml lysis buffer (4% (v/v) sodium
dodecyl sulphate (SDS), 50 mM tetraethylammonium bromide
(TEAB) pH 8.5 and 10 mM tris(2-carboxyethyl)phosphine
hydrochloride (TCEP)), and incubated at 22°C under agitation
(500 rpm on Thermomixer) for 5 minutes. Following the
incubation, the lysates were boiled for 5 minutes under
agitation (500 rpm on Thermomixer). The lysates were cooledFrontiers in Immunology | www.frontiersin.org 3and sonicated for 15 cycles of 30-seconds-on and 30-seconds-off
using a UP200St with VialTweeter (Hielscher Ultrasound
Technology) without cooling. The concentration of proteins in
the cell lysates was determined using an EZQ protein
quantitation kit (Invitrogen) as per manufacturer instructions.
Following protein quantitation, the samples were incubated with
20 mM iodoacetamide for 1 hour at 22°C in the dark to alkylate
reduced cysteines.
Paramagnetic beads were used for protein clean-up and digest
according to the Single-Pot Solid-Phase-enhanced Sample
Preparation (SP3) procedure (46). Briefly, 200 mg of a 1:1 mix
of Hydrophobic and Hydrophilic Sera-Mag SpeedBead
Carboxylate-Modified Magnetic Particles were added to each
protein sample. The samples were acidified by the addition of
550 ml 10:1 acetonitrile:formic acid. The samples were then
incubated at 22°C under agitation (500 rpm on Thermomixer)
for 8 minutes to allow the proteins to bind to the beads. The
bead-protein complexes were immobilized using a magnetic rack
and the supernatant was removed before washing the complexes
once with 70% (v/v) ethanol and then once with acetonitrile.
After air drying, the beads were resuspended in digest buffer
(0.1% (v/v) SDS; 50 mM TEAB, pH 8.5; 1 mM CaCl2). LysC
(Wako) was added at a ratio of 50:1 protein:LysC and incubated
for 16 hours at 37°C. Then Trypsin (Promega) was added at a
ratio of 50:1 protein:Trypsin, and left for 24 hours at 37°C. After
the incubation with the proteases, acetonitrile was added to the
digest mix, to give a final concentration of >95% (v/v)
acetonitrile. The samples were mixed and incubated upright
for 8 minutes without agitation, followed by incubation for 2
minutes on a magnetic rack to immobilise the beads. The
acetonitrile/digest buffer mix was removed, and the bead-
peptide complexes were washed using acetonitrile. To elute the
peptides, 2% (v/v) DMSO was added to the beads before
sonication (5 cycles of 30 seconds on and 30 seconds off,
without cooling). The supernatant containing the peptides was
removed into a fresh tube. Formic acid was added to the peptides
to give a final concentration of 5% (v/v) formic acid.
Peptide Fractionation
Peptide samples for proteomic analysis were fractionated off-line
by high pH reverse-phase liquid chromatography using an
UltiMate 3000 BioRS system equipped with a 2.1 mm ×
150 mm Xbridge Peptide BEH C18 column with 3.5 mm
particles (Waters). For the separation, the buffers used were
10 mM ammonium formate at pH 9 in 2% (v/v) acetonitrile
(RPLC buffer A) and 10 mM ammonium formate at pH 9 in 80%
(v/v) acetonitrile (RPLC buffer B). The samples were separated
using a 25 minute multistep gradient of RPLC buffer A and
RPLC buffer B at a flow rate of 0.3 ml per minute. Peptides were
separated into 16 fractions using a concatenation collection
method. The fractions were dried using a SpeedVac (Genevac).
Liquid Chromatography-Mass
Spectrometry
Mass spectrometry was performed by the Proteomics Facility,
University of Dundee, UK. Analysis of peptides was performedSeptember 2021 | Volume 12 | Article 712402
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coupled with a Dionex Ultimate 3000 RS (Thermo Scientific).
The liquid chromatography (LC) buffers were LC buffer A (0.1%
(v/v) formic acid in Milli-Q water) and LC buffer B (80% (v/v)
acetonitrile, 0.08% (v/v) formic acid in Milli-Q water).
Dried peptide samples were reconstituted in 50 µl of 1% (v/v)
formic acid and 7 ml of each sample were loaded at 10 ml/min
onto a trap column (100 mm × 2 cm, PepMap nanoViper C18
column, 5 mm, 100 Å, Thermo Scientific) equilibrated in LC
buffer A for 19 minutes. The trap column was washed for 3
minutes at the same flow rate before the trap column was
switched in-line with a Thermo Scientific resolving C18
column (75 mm × 50 cm, PepMap RSLC C18 column, 2 mm,
100 Å) kept at a constant temperature of 50°C and equilibrated in
2% LC buffer B for 19 minutes. Peptides were eluted from the
column at a constant flow rate of 300 nl/minute with a linear
gradient from 2% LC buffer B to 5% LC buffer B within 3
minutes, then from 5% LC buffer B to 35% LC buffer B in 124
minutes and finally from 35% LC buffer B to 98% LC buffer B in 2
minutes. The column was then washed for 20 minutes at 98% LC
buffer B and re-equilibrated in 2% LC buffer B for 19 minutes.
The LTQ Orbitrap Velos Pro was operated in data dependent
positive ionization mode using an Easy-Spray nanoelectrospray
ion source (Thermo Scientific). The source voltage was set to 1.9
Kv and the capillary temperature was 250°C. A scan cycle
comprised MS1 scan (m/z range from 335-1800) in the Velos
Pro Orbitrap followed by 15 sequential dependant MS2 scans
(the threshold value was set at 5,000 and the minimum injection
time was set at 200 ms) in the LTQ (Linear Trap Quadrupole)
with collision induced dissociation using the following
parameters: isolation width 2, normalized collision energy 35,
default charge state 2, activation Q 0.25 and activation time, 10 ms.
The resolution of the Orbitrap Velos was set to 60,000 after
accumulation of 1,000,000 ions. Precursor ion charge state
screening was enabled, with all unassigned charge states and
singly charged species rejected. The lock mass option was enabled
for survey scans to improve mass accuracy. To ensure mass
accuracy, the mass spectrometer was calibrated on the first day
that the runs were performed.
Proteomic Data Processing and Analysis
The mass spectrometry data files were processed using
MaxQuant version 1.6.0.1 and spectra were mapped to the
reviewed UniProtKB mouse protein database and the
contaminant database supplied by MaxQuant. The following
search parameters were used: trypsin and LysC were selected as
the proteases; up to two missed cleavages were permitted; the
minimum peptide length was set to 6 amino acids; protein
N-terminal acetylation, methionine oxidation, glutamine to
pyroglutamate, glutamine and asparagine deamidation were
selected as variable modifications; carbamidomethylation of
cysteine residues was set as a fixed modification; MS tolerance
of 20 ppm and MS/MS tolerance of 0.5 Da; label free
quantification was enabled. False discovery rates (FDRs) were
set to 0.01 and based on hits against the reversed sequence
database. This cut-off was applied to individual spectra and
whole proteins in the MaxQuant output. The match betweenFrontiers in Immunology | www.frontiersin.org 4runs function was enabled. Proteins were quantified on the basis
of unique (found only in a specific protein group) and razor
peptides (peptides assigned to a specific protein group without
being unique to that group) with the re-quantification
feature enabled.
Following processing of the files by MaxQuant, Perseus
software version 1.5.2.6, was used to annotate proteins with
gene ontology (GO) terms for biological process (BP), molecular
function (MF), cellular compartment (CC), and KEGG
pathways; filter the MaxQuant output to remove known
contaminants, reverse sequences and proteins only identified
based on a modification site; and calculate estimated copy
numbers of proteins per cell.
The proteome ruler plug-in was implemented in Perseus to
assign copy numbers of histones in a diploid mouse cell to the
summed peptide intensities of all histones in each sample. From
this, Perseus used the peptide intensities associated with the
other proteins identified in the dataset to estimate their copy
numbers per cell (47). The accuracy of the quantification of each
protein was annotated according to the number of peptides and
percentage of unique peptides identified for the protein as
follows: high: ≥8 peptides detected, minimum of 75% unique
peptides; medium: ≥3 peptides detected, a minimum of 50%
unique peptides; low: all other peptides.
To evaluate changes to the CTL proteome induced by
hypoxia, the estimated copy numbers were used to determine
the ratio of expression of individual proteins within biological
replicates. The significance of these changes was determined by
performing a two-tailed paired Student’s t-test, without further
adjustment, on Log2-normalized copy numbers for each protein
in normoxia and hypoxia using Microsoft Excel. Proteins were
defined as significantly regulated if they had a ratio of ≥1.5 or ≤
0.67, if they were identified in two out of three replicates, if they
were reproducibly regulated in all replicates in which they were
identified, and if they had a P value of ≤0.05.
The proteins identified as being up- or down-regulated were
subjected to enrichment analysis for KEGG pathways, using a
custom background comprising of all proteins identified in the
dataset. The enriched KEGG pathways were grouped using the
functional annotation clustering tool of DAVID (version 6.8),
using a medium clustering stringency and an EASE (Expression
analysis systematic explorer) score, a modified Fisher Exact P
value, of ≤1.
Copy numbers were additionally used to calculate the mass of
specific proteins, or groups of proteins, per cell. For each protein,
the following formula was used to calculate its total mass per cell:
Mass of proteins (in grams per cell) = [(protein copy number)/
Avogadro’s constant] × molecular weight of protein (Daltons).
When specific groups of proteins were analysed, for example
glycolytic enzymes, the proteins were manually filtered in Excel,
based on KEGG pathway annotation by Perseus.
Lactate Output Measurements
Lactate measurements were performed as described previously
(28, 34). Briefly, CTL that had been seeded and maintained in
normoxia or subjected to hypoxia for 24 hours as described in
“24-hour hypoxia treatments” were counted and resuspended toSeptember 2021 | Volume 12 | Article 712402
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dialysed serum equilibrated in the appropriate oxygen
atmosphere. The cells were incubated for a further 4 hours in
the appropriate oxygen environment. Following incubation, the
media supernatants were collected. The concentration of lactate
released into the media was determined using an enzymatic assay
in which lactate dehydrogenase (LDH) was used to oxidise
lactate and the reduction of NAD+ to NADH was measured by
absorption at 340 nM. To determine lactate concentration, an
equal volume of sample and mastermix (320 mM glycine, 320
mM hydrazine, 2U lactate dehydrogenase and 2.4 mM NAD+)
were mixed together and samples incubated for 10 minutes at
room temperature. Absorbance of the reactions was then read at
340 nM using a cytofluor II Fluorescence Multi-Well Plate
Reader (Perceptive BioSystems). Lactate standards were used to
generate a standard curve and the concentration of lactate in the test
samples inferred following data analysis in Prism (GraphPad).
Protein Synthesis Analysis
CTLs that had been seeded as described in “24-hour hypoxia
treatments” were counted 24 hours later and resuspended to a
final concentration of 1x106 cells/ml in fresh RPMI 1640 with
10% FBS, 50 units/ml penicillin-G, 50 mg/ml streptomycin,
50 mM b-mercaptoethanol and 20 ng/ml IL-2 equilibrated to
the appropriate oxygen atmosphere. The CTLs were incubated
with 20 µM O-propargyl-puromycin (OPP, Jena Bioscience) for
10 minutes at 37°C in normoxia (18% O2) or hypoxia (1% O2).
Control cells cultured at 18% O2 were pre-treated with
cycloheximide for 30 minutes before addition of OPP. OPP
incorporation into polypeptide chains was terminated by fixing
cells with 1% paraformaldehyde for 15 minutes at 22°C. After
fixation, cells were washed in 0.5% (v/v) FBS in PBS before being
permeabilised with 0.5% (v/v) Triton X-100 in PBS for 15
minutes at 22°C. The incorporated OPP was then labelled with
Alexa 647-azide using a standard Click-IT chemistry reaction
(ThermoFisher Scientific) for 30 minutes at 22°C. Cells were
washed twice with 0.5% FBS (v/v) in PBS, before being
resuspended in 0.5% FBS (v/v) in PBS for analysis. Data were
acquired on a LSRFortessa flow cytometer with DIVA software
(BD Biosciences). Data analysis was performed with FlowJo
software (Treestar).
Cell Cycle Analysis
CTLs seeded as described in “24-hour hypoxia treatments” were
counted and resuspended to a final concentration of 1x106 cells/ml
in fresh RPMI 1640 with 10% FBS, 50 units/ml penicillin-G, 50 mg/
ml streptomycin, 50 mM b-mercaptoethanol and 20 ng/ml IL-2
equilibrated to the appropriate oxygen atmosphere. CTLs were
incubated with 10 mM EdU (ThermoFisher Scientific) at 37°C for
30minutes to evaluate DNA synthesis in normoxia (18% O2) or
hypoxia (1%O2). To terminate DNA synthesis, cells were fixed with
1% paraformaldehyde for 15 minutes at 22°C. Following fixation,
cells were washed in 0.5% (v/v) FBS in PBS, and permeabilised with
0.5% (v/v) Triton X-100 in PBS for 15 minutes at 22°C. The
incorporated EdU was labelled with Alexa 647-azide using a
Click-IT chemistry reaction (ThermoFisher Scientific) at 22°C.
After a 30 minute reaction, cells were washed twice using 0.5%Frontiers in Immunology | www.frontiersin.org 5(v/v) FBS in PBS. Cells were then stained with 50mg/ml propidium
iodide in the presence of 50mg/ml ribonuclease A for 30 minutes at
22°C. Cells were resuspended in 0.5% (v/v) FBS in PBS for analysis.
Data were acquired on a LSRFortessa with DIVA software (BD
Biosciences). Data were analysed using FlowJo software (Tree Star).
Antigen Receptor Triggering and
ELISA Assays
Cells maintained in normoxia (18% O2) or hypoxia (1% O2) for
24 hours as described in “24-hour hypoxia treatments” were
counted and resuspended in media (equilibrated to the
appropriate gas environment overnight) at a concentration of
1×106 cells per ml in RPMI 1640 with 10% FBS, 50 units/ml
penicillin-G, 50 mg/ml streptomycin, 50 mM b-mercaptoethanol
and 20 ng/ml IL-2. 1 ml of the cell suspension was plated per well
of a 24 well plate. Cells were either mock stimulated with media,
or stimulated with 100 ng/ml gp-33 peptide in the appropriate
oxygen environment. After 4 hours, the supernatants from the
wells were collected and subjected to ELISA analysis for IFNg
(IFN gamma ‘Femto-HS’ High Sensitivity Mouse Uncoated
ELISA Kit, ThermoFisher Scientific), TNFa (TNF alpha Mouse
ELISA Kit, ThermoFisher Scientific) and IL-10 (ELISA MAX™
Standard Set Mouse IL-10, BioLegend) according to the
manufacturers’ protocols. Several serial dilutions of each
sample were performed, to ensure that the sample detection
was within the linear range of the ELISA kits. GraphPad Prism
was used to fit standard curves, and determine the
concentrations of IFNg, TNFa and IL-10 in the samples.
Statistical Analyses
Statistical analyses of changes in protein abundance from the
proteomic data were performed as outlined in ‘Proteomic data
processing and analysis’. Data derived from the proteomic
studies (such as the mass of cells or mass of glycolytic enzymes
per cell) and validation data were subjected to similar statistical
analyses using a two-tailed paired Student’s t-test, without
further adjustment.RESULTS
Hypoxia Reconfigures the CTL Proteome
Selectively
We generated a primary culture of CTLs from P14 TCR
transgenic mice and then exposed a population to a gas
atmosphere of 1% oxygen for 24 hours whilst maintaining a
parallel population in standard culturing conditions with a gas
atmosphere of 18% O2. In these experiments, CTLs were
maintained in IL-2 to sustain viability and effector function.
We then used quantitative high-resolution mass spectrometry to
determine the proteomes of the CTLs maintained in normoxia
(18% O2) versus hypoxia (1% O2). For each condition, over 7,600
protein groups were identified (Figure 1A and Supplementary
Figures S1A, B, Supplementary Table S1), and there was >97%
overlap in the proteins identified between biological replicates
(Supplementary Figures S1A, B). Protein copies per cell wereSeptember 2021 | Volume 12 | Article 712402
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mass spectrometry signal of histones as an internal standard,
providing normalised and quantitative data that is determined
independently from the numbers of cells or total protein content
of the sample (47).
The correlation between estimated copy numbers of proteins
in different biological replicates of each condition was good, with
the lowest R2-value being 0.91 (Supplementary Figures S1C, D).
These data revealed that there was a slight increase in protein
mass in the hypoxic T cells (Figure 1B and Supplementary
Table S2). This correlated with flow cytometry analysis which
indicated that CTL subjected to hypoxia had a slight increase in
forward scatter (FSC), and a larger increase in side scatter (SSC)
(Figures 1C, D). Using the protein copy number data, we
calculated ratios of protein abundance of ~7,600 proteins thatFrontiers in Immunology | www.frontiersin.org 6were identified in both normoxic and hypoxic CTLs (Figure 1E
and Supplementary Table S1).
Consistent with cells being exposed to low oxygen levels, we
detected an increase in HIF1a expression in CTL subjected to 1%
oxygen (Figure 1F), which we have previously observed in CTLs
(34). The increase in HIF1a expression was not found to be
statistically significant. However, in accordance with activation
of HIF1a-mediated transcription, we observed an increase in the
abundance of the proteins encoded by HIF1 target genes notably
the prolyl hydroxylases PHD2 (Figure 1G) and PHD3
(Figure 1H) and the transcription factor NFIL3 (Figure 1I).
In total, we identified 340 proteins that were significantly
(P ≤0.05, two-tailed paired t-test) increased by >1.5-fold in
response to hypoxia (Supplementary Table S1). The 20





FIGURE 1 | The impact of hypoxia on the CTL proteome. (A) Venn diagram showing the overlap of proteins identified in the proteomic analysis of IL−2 maintained
CTLs in normoxia (18% O2) and IL−2 maintained CTLs subjected to hypoxia (1% O2) for 24 hours. (B) Protein content of CTLs in normoxia or subjected to hypoxia
for 24 hours calculated using the proteomic data. (C) Representative flow cytometry FSC and SSC profiles for CTLs in normoxia or after 24 hours in hypoxia. (D) Bar
charts showing the average of the geometric mean for the FSC and SSC profiles of three biological replicates of CTLs maintained in normoxia or subjected to
hypoxia for 24 hours which were acquired at the same time. (E) Volcano plot showing the ratio of the protein copy number in CTLs in hypoxia for 24 hours
compared to CTL maintained in normoxia, plotted against P value (two-tailed paired t-test). Proteins significantly changed (P ≤0.05) by greater than 1.5-fold are
shown in red. (F–I) Copy numbers estimated from the proteomic data for the indicated proteins. Data show (A, B, D–I), or are representative of, (C), three biological
replicates. In bar charts, data points from each of the three biological replicates are shown and are colour matched, the bar shows the mean and the error bars
show standard deviation. P values were calculated using a two-tailed paired t-test. Non-significant changes are marked NS.September 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL ProteomeInterleukin-1 receptor type 2 (IL1R2, also known as CD121b)
which acts as a decoy receptor for IL-1, which had <15-fold
higher abundance in hypoxic cells than normoxic cells; the serine
proteinase inhibitor, SERPINE1; and a predicted transmembrane
protein, TMEM71. The top 20 proteins most increased in
response to hypoxia also included NDRG1 which has been
linked to driving T cell anergy (48).
Interestingly, only 42 proteins were significantly decreased >1.5-
fold in CTL in response to hypoxia (Supplementary Table S1).
Of these, the proteins that were most decreased in abundance in
hypoxia included NDUFA4, which is a subunit of the cytochrome c
oxidase which drives oxidative phosphorylation; fatty acid
desaturase 1 (FADS1), succinate dehydrogenase cytochrome b560
subunit (SDHC); and the transcription factor eomesodermin
(EOMES) (Supplementary Table S1).Frontiers in Immunology | www.frontiersin.org 7Impact of Hypoxia on CTL Metabolism
KEGG pathway clustering analysis revealed that the proteins
increased in abundance in hypoxic CD8+ T cells were enriched in
proteins involved in glycolytic metabolism (Figure 2A and
Supplementary Table S1). Indeed, our proteomic data revealed
the magnitude of this response. While approximately 8% of the
mass of the P14 CTLs in normoxia comprised of glycolytic enzymes
(Figure 2B and Supplementary Table S2), hypoxia triggered
glycolytic enzymes to double in abundance in CTLs, increasing
their dominance to ~12% of the CTL proteome (Figure 2B and
Supplementary Table S2). This included substantial increases in
rate-limiting enzymes for glycolysis (49), hexokinase 1 (HK1),
hexokinase 2 (HK2) and phosphofructokinase (PFK) platelet and
liver isoforms, which were expressed at 2-3 times higher levels in
hypoxic CTL than normoxic CTL (Figures 2C–F). Indeed, allA
B
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FIGURE 2 | Hypoxia-mediated changes to proteins involved in glucose metabolism. (A) Proteins increased in abundance in CTLs after 24 hours in hypoxia were
evaluated for function using DAVID. The bar chart shows the enrichment scores for the clusters. (B) Graph showing the estimated mass of proteins in a cell,
calculated using the proteomic ruler, annotated with the KEGG pathway term “glycolysis”. (C–J) Copy numbers estimated from the proteomic data for the indicated
proteins. (K) Lactate output in normoxic and hypoxic CTLs. (L) Bar chart showing the estimated mass of proteins in a cell, calculated using the proteomic ruler,
annotated with the KEGG pathway term “Oxidative phosphorylation”. (M, N) Volcano plots showing the protein copy number ratio in hypoxic vs normoxic CTLs. In
(M) mitochondrial proteins involved in oxidative phosphorylation and metabolite transport are shown in red, with selected proteins annotated. In (N) proteins
increased in abundance in hypoxic CTLs and involved in cellular glycosylation are highlighted in red and are annotated. Data in (A–N) show three biological
replicates. In bar charts, data points from the individual biological replicates are shown and are colour matched, the bar shows the mean and the error bars show
standard deviation. P values were calculated using a two-tailed paired t-test. Non-significant changes are marked NS.September 2021 | Volume 12 | Article 712402
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(Supplementary Figure S2).
Hypoxia also increased the abundance of glucose and lactate
transporters which are known to be rate limiting for glycolysis
(49). CTLs express the glucose transporters SLC2A1 (also known
as GLUT1) and SLC2A3 (also known as GLUT3) and the
expression of both increased in response to oxygen deficiency
(Figures 2G, H). SLC2A1 increased from ~60,000 copies per cell
in normoxia to ~260,000 copies per cell in hypoxia, and SLC2A3
increased from ~130,000 copies per normoxic CTL to ~760,000
copies per hypoxic CTL. We identified the lactate transporters
SLC16A1 (MCT1) and SLC16A3 (MCT4) in CTL. While there
was a moderate impact of hypoxia on SLC16A1, SLC16A3
increased from ~240,000 copies per normoxic CTL to ~690,000
copies per hypoxic CTL (Figures 2I, J). These dramatic changes in
expression of the rate limiting transporters for glycolysis suggested
that CTLs in hypoxia might increase glycolytic metabolism.
Accordingly, we measured lactate output to quantify glycolysis
and found that there was an increase in lactate released into the
extracellular environment from CTLs that had adapted to hypoxia
compared to CTLs maintained in normoxia (Figure 2K).
The increase in abundance of glycolytic enzymes in hypoxic
CTLs was not accompanied by substantial changes in the total
mass of enzymes involved in oxidative phosphorylation
(Figure 2L and Supplementary Table S2). However, we did
detect decreases in specific components of the mitochondrial
oxidative phosphorylation machinery. This included succinate
dehydrogenase cytochrome b560 subunit (SDHC), belonging to
complex II (50), which decreased in abundance ~2 fold in
hypoxic cells (Figure 2M); ubiquinol-cytochrome c reductase
binding protein (UQCRB), which is part of complex III (51), also
decreased in abundance ~2 fold in response to hypoxia; and
NDUFA4, which was thought to belong to complex I, but is now
thought to be important for the function of complex IV (52),
decreased ~10-fold in response to hypoxia. Consequently,
although there is not an overall decrease in the total mass of
enzymes associated with mitochondria, there could be a change
in oxygen consumption by cells in response to hypoxia as a
consequence of loss of these specific components.
There were no changes in expression of mitochondrial
transport proteins that are responsible for transporting
metabolites between the cytosol and mitochondria (Figure 2M
and Supplementary Table S1). This includes the highly
abundant SLC25A4 and SLC25A5, that transport ADP from
the cytoplasm into the mitochondrial matrix and ATP from the
mitochondrial matrix into the cytoplasm, and SLC25A3, which
transports phosphate into mitochondria.
We also assessed if hypoxia induced a change in the
abundance of proteins that control other glucose metabolic
pathways. We found that hypoxia had no impact on
expression of the key enzymes that mediate the TCA cycle, but
we did observe modest changes in expression of proteins of the
pentose phosphate pathway (PPP) namely 6-phosphogluconate
dehydrogenase and Transketolase (Supplementary Figure S3).
We also observed that hypoxia triggered an increase in
expression of SLC35A1 and SLC35A2 (Figure 2N), transportersFrontiers in Immunology | www.frontiersin.org 8that deliver nucleotide-sugars into the Golgi apparatus or Golgi
vesicles. In addition, several proteins that control protein
glycosylation were increased in abundance in hypoxic T cells
including polypeptide N-acetylgalactosaminyltransferase 6 and
beta-galactoside alpha-2,6-sialyltransferase 1 (Figure 2N). We also
noted that hypoxia increased abundance of isocitrate dehydrogenase
(IDH1), which is involved in the metabolism of glutamine, ATP-
citrate synthase (ACLY), which metabolises citrate, and acetyl-
coenzyme A synthetase (ACSS2), which metabolises acetate
(Supplementary Figure S2).
Impact of Hypoxia on Protein Biosynthesis
Machinery
Changes to the proteome depend on transcription and
translation. The substantial increase in the highly abundant
glycolytic enzymes are consistent with substantial levels of
protein synthesis. Yet, it has been reported that severe hypoxia
limits protein translation in cells to conserve energy (43, 53, 54).
CTLs are known to express high levels of ribosomes, tRNA
synthetases, eukaryotic initiation factor 4 (eIF4) complexes that
translate methyl capped mRNAs and EIF2 complexes which
control tRNA transfer to ribosomes (5). Our experiments
revealed no substantial loss of ribosome mass (Figure 3A and
Supplementary Table S2) or any of these key translational
complexes in hypoxic T cells (Figures 3B, C). We did not
detect any up-regulation of translational repressors such as 4E-
BP1 and 4E-BP2 (55), which bind to eIF4E to prevent the
assembly of translational initiation complexes, or PDCD4,
which inhibits translation by binding to EIF4A1 (56)
(Figure 3B). We identified EIF4E2 and EIF4G3 (Figure 3D)
components of the EIF4FH mRNA cap-binding complex
activated during hypoxia and several poly(A) RNA binding
proteins (Supplementary Table S1) that have been linked to
reprogramming the translatome of cells to allows cells to adapt to
low oxygen (43). None of these proteins appear to increase in
response to hypoxia, and the abundance of the EIF4FH is
relatively low compared to the basal EIF4F complex
(comprising of EIF4E1 and EIF4G1). Interestingly, our data
indicated there was an increase in EIF4A2 (Figure 3E), a
paralog of EIF4A1, which can act as a translational repressor
in some contexts (57). Moreover, hypoxic T cells retained high
levels of expression of critical amino acid transporters, such as
the system L transporter SLC7A5, (Figure 3F) that fuels protein
synthesis in CTL (58, 59). These data suggest that overall, CTLs
experiencing hypoxia retain the cellular machinery required to
carry out protein synthesis, and do not upregulate proteins that
are known to reprogramme translation in response to hypoxia.
In order to assess the activity, rather than the abundance, of
the protein synthesis machinery in hypoxic CTL, we used a
quantitative single-cell assay that measures protein synthesis by
detecting the catalytic incorporation of O-propargyl-puromycin
(OPP), an analogue of puromycin and aminoacyl-tRNA
mimetic, into elongating nascent protein chains in the
ribosome. These experiments determined that CTLs in
normoxia and hypoxia incorporated high levels of OPP. There
was a small reduction in OPP incorporated by hypoxic CTLSeptember 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL Proteomecompared to normoxic cells (Figures 3G, H), suggesting that
while the abundance of the translational machinery was not
impacted by hypoxia, there may be an impact on its activity.
However, this was not a substantial effect. Indeed, the increased
abundance of highly abundant cellular glycolytic enzymes and
the overall increase in cell mass and expression of more than 300
proteins in CTL cultured in 1% O2 is consistent with hypoxic
CTL retaining relatively high protein synthetic capacity, as well
as the preferential translation of genes required for the
adaptation to hypoxia.
Hypoxia Limits the Proliferation of IL-2
Maintained CTLs
Cell cycle arrest and inhibited proliferation is triggered in many
cell types in response to hypoxia (60). In T cells, low oxygen hasFrontiers in Immunology | www.frontiersin.org 9been reported to inhibit (18, 22–25) or increase (61, 62) CD8+ T
cell proliferation in different contexts. CTLs cultured in
normoxia clonally expand when maintained in exogenous IL-2.
We, therefore, investigated the proliferation of CTLs that were
generated by activating naïve P14 CD8+ T cells with peptide
antigen for 48 hours before differentiation in IL-2 for 3 days in
normoxia. These cells were then either maintained in IL-2 in
normoxia or maintained in IL-2 and subjected to hypoxia, with
cell counts being taken 24 and 48 hours after cells were first
exposed to hypoxia. Cell counting revealed that the CTLs in
hypoxia survive, but do not proliferate (Figures 4A, B). To
determine if hypoxia caused T cells to arrest at any particular
stage of the cell cycle, we assessed the DNA content of the cells
using the DNA-binding dye propidium iodide and evaluated





FIGURE 3 | Regulation of protein synthesis machinery by hypoxia. (A) Graph showing the estimated mass of proteins in a cell, calculated using the proteomic ruler,
annotated with the KEGG pathway term “ribosome” for CTLs maintained in normoxia (18% O2) or subjected to 24 hours of hypoxia (1% O2). (B–D) Schematic
representation of the EIF4 complex (B) and EIF2 complex (C) and the EIF4FH complex (D). P(A)RBP stands for poly(A) RNA binding proteins. Average copy numbers
for three biological replicates of CTLs maintained in normoxia or subjected to 24 hours of hypoxia are annotated alongside. (E) Copy numbers estimated from the
proteomic data for EIF4A2. (F) Volcano plot showing the protein copy number ratio in hypoxic vs normoxic CTLs with amino acid transporters highlighted in red and
annotated. (G, H) Protein synthesis of CTLs maintained in normoxia or subjected to 24 hours of hypoxia was evaluated using the puromycin analogue, OPP using a
flow-cytometry-based assay. Normoxic CTLs were pre-treated with cycloheximide (CHX) for 30 minutes to block translation before the addition of OPP.
Representative flow cytometry plots of one biological replicate of the OPP incorporation are shown in (G) and the geometric mean of the fluorescence intensity for all
three biological replicates acquired at the same time are shown in (H). Data in (A), (E, F) show three biological replicates; data in (B–D) show average values from
three biological replicates. In bar charts, data points from biological replicates are shown and are colour matched, the bar shows the mean and the error bars show
standard deviation. P values were calculated using a two-tailed paired t-test. Non-significant changes are marked NS.September 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL ProteomeDNA. We detected both of these parameters by flow cytometry.
Hypoxic CTLs showed decreased EdU incorporation compared
to control CTLs in 18% O2 (Figures 4C, D). These data reveal
that CTLs experiencing hypoxia are impaired in their ability
to progress through S phase and hence fail to proliferate. It has
been proposed that PHD1-mediated prolyl hydroxylation of
the centrosomal protein Cep192 regulates its proteasomal
degradation, and its abundance on the centrosome to control
the formation of the mitotic spindle (38). We found that the
frequency of hypoxic CTLs in the G2-M phase of the cell cycleFrontiers in Immunology | www.frontiersin.org 10is ~5% which is ~1.5 fold of the frequency of that measured in
normoxic T cells (Figure 4E). This could indicate some delay in
mitosis in hypoxic CTLs, however, the cell cycle phenotype was
not consistent with a full mitotic block. Moreover, we did not
detect PHD1 nor Cep192 in CTLs. Thus, changes to DNA
synthesis appear to be the major driver of the changes in
proliferation of hypoxic CTLs.
In cancer cells, changes in DNA replication have been
associated with decreased levels of MCM proteins, and





FIGURE 4 | Inhibition of the cell cycle by hypoxia. (A) Viability of CTL maintained in normoxia or subjected to hypoxia for 24 hours or 48 hours as determined by
flow cytometry forward scatter (FSC) and side scatter (SSC) and DAPI staining. (B) Proliferation of CTLs in normoxia or hypoxia over 48 hours. (C–E) Flow cytometric
analysis of cell cycle stages in CTLs maintained in normoxia or after 24 hours of hypoxia using EdU incorporation into DNA. Representative flow plots of DNA stained
with PI against EdU incorporation are shown in (C), and a histogram of EdU incorporation alone is shown in (D). The percentage of CTL identified as in G2 is shown
in (E). (F) Schematic representation of selected cyclin levels during the cell cycle, with bar charts showing copy numbers estimated from the proteomic data for the
indicated cyclins and CDKs shown alongside. (G) Copy numbers for thymidine kinases estimated from the proteomic data. Data in (A, B) and (E–G) show three
biological replicates. Data in (C, D) are representative of three biological replicates. In bar charts, data points from individual biological replicates are shown and are
colour matched, the bar shows the mean and the error bars show standard deviation. P values were calculated using a two-tailed paired t-test. Non-significant
changes are marked NS.September 2021 | Volume 12 | Article 712402
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(60). We interrogated the proteomic data to determine whether
hypoxia altered the abundance of key cell cycle regulatory
proteins. We did not detect changes in the abundance of
MCM proteins in our proteomics analysis. Normoxic and
hypoxic T cells expressed similar levels of the D2 type cyclins,
Cyclins D2 and D3, and the associated cyclin dependent kinases
CDK4 and CDK6, but CTLs in hypoxia had increased expression
of cyclin A2 (Figure 4F). However, hypoxic CTLs showed
decreased abundance of thymidine kinase 1 (Figure 4G) which
synthesises thymidine monophosphate from thymidine, a crucial
phosphorylation step that is required to allow thymidine to be
incorporated into DNA (63). Therefore, this decrease in TK1
could explain the decreased DNA synthesis rates seen in hypoxic
CTLs. However, as the abundance of TK1 and cyclins are
regulated by the cell cycle, it is unclear whether changes in
expression of these proteins is a cause, or a consequence, of
changes to the altered cell cycle progression of hypoxic CTLs.
Hypoxia Controls Expression of CTL
Effector Molecules
Previous studies have shown that in both normoxia and hypoxia,
the expression of the CTL effector molecule, perforin is
controlled by HIF1-dependent signalling pathways mediated
by the transcription factor NFIL3 (34). Our proteomic data
confirmed an increase in the abundance of perforin in hypoxic
CTL (Figure 5A), and also showed that hypoxic CTLs increase
the abundance of granzyme A, as well as the lower abundance
granzyme D, granzyme E and granzyme G (Figure 5A). Perforin
and granzymes are stored within specialised secretory lysosomes
marked by the lysosomal proteins LAMP1 (also known as
CD107a) and LAMP2. There was no substantial increase in
LAMP1 or LAMP2 expression in hypoxic CTLs (Figure 5B).
Moreover, expression of the GTPase RAB27A and STXBP2
(MUNC18-2), UNC13D (MUNC13-4) which control the
regulated secretion of T cell cytolytic granules did not
substantially, or reproducibly, change in abundance in hypoxic
CTL (Figure 5B). These data reveal that hypoxia did not
generally increase the quantity of secretory machinery or
secretory lysosomes in CTL, but rather stimulated the loading
of granules with effector molecules, consistent with previous
studies (23).
Another effector function of CTL is to secrete cytokines and
the current experiments detected IL-10, IL-24, TNF and LTA in
both normoxic and hypoxic CTL (Supplementary Table S1).
There were decreases in the expression of TNF and LTA in
response to hypoxia but more striking was the increased
expression of the anti-inflammatory cytokine IL-10
(Figure 5C) and IL-24 (Figure 5D), another IL-10 family
member. Previously IL-10 has been shown to increase in
hypoxic CTLs in response to TCR triggering (22), but also in
unchallenged hypoxic CTLs (23). To validate that CTL
in hypoxia secreted more IL-10 in the absence of exogenous
antigen, we used an ELISA assay. We found that CTL in
normoxia only secreted low levels of IL-10, however, CTLFrontiers in Immunology | www.frontiersin.org 11adapted to hypoxia showed increased production of
IL-10 (Figure 5E).
IFNg is an important pro-inflammatory cytokine produced
by CTLs during an immune response. We did not detect
intracellular IFNg in CTL cultured in normoxia or hypoxia in
our proteomic dataset. This may reflect that this cytokine is
immediately secreted from CTLs and is not stored in any
intracellular compartment. Therefore, we used ELISAs to
examine the impact of hypoxia on basal and antigen receptor
induced production of IFNg by CTLs. We found that hypoxia
did not impair the low basal IFNg production by CTLs
(Figure 5F). However, antigen-stimulated IFNg was decreased
in CTLs that had adapted to hypoxia for 24 hours (Figure 5F).
Moreover, we detected a similar reduction of TNFa production
in hypoxic CTLs compared to normoxic CTLs (Figure 5G).
Hypoxia Regulation of T Cell Membrane
Proteins
Previous flow cytometry studies have shown that HIF mediated
signalling pathways control the expression of the costimulatory
molecules CD137, OX40, and GITR, and the inhibitory
checkpoint receptors PD-1, TIM3, and LAG3 (26). In our
unbiased proteomic analyses, we identified that hypoxia
upregulated multiple stimulatory checkpoint receptors,
including ICOS, GITR, 4-1BB, and OX40, and inhibitory
receptors PD-1, CTLA-4, Tim-3 and Lag-3 (Figure 6A). In
contrast, expression of the T cell antigen receptor complex
(Figure 6B) and other costimulatory molecules such as CD160
and CD244 (2B4) (Figure 6A) remained relatively unchanged.
However, we did detect an increase in the abundance of the
CD3ϵ (T-cell surface glycoprotein CD3 epsilon chain) and CD3z
(T-cell surface glycoprotein CD3 zeta chain) components of the
T cell receptor (Figure 6B). Within hypoxic tumours, elevated
levels of adenosine have been shown to be an important
metabolic checkpoint by which T cells are inhibited (64, 65).
However, we did not identify the A2A adenosine receptor nor
the A2B adenosine receptor in our proteomic dataset.
One new insight from this quantitative proteomic data, that
cannot be determined from flow cytometry or mRNA data, is the
differential abundance of the different costimulatory and
inhibitory checkpoint receptors on CTLs. Normoxic CTLs
express approximately ~7×104, ~8×103 and ~6×103 copies of
the inhibitory checkpoint molecules LAG3, TIM3 and CTLA4
respectively, with PD-1 being the least abundant at ~2.5×103
molecules per cell. In addition, under normoxia, CTLs expressed
~6×104, ~2×104 and ~7×103 molecules of the costimulatory
molecules 4-1BB, GITR and OX40 respectively (Figure 6B). In
response to hypoxia, LAG-3 increases ~4.5-fold to ~3×105 copies
per cell, becoming the most abundant inhibitory or stimulatory
checkpoint receptor expressed by CTLs (Figure 6B). Interestingly,
as GITR increased ~5-fold, compared to the ~1.5-fold induction
of 4-1BB, these molecules were subsequently expressed at a
similar level of ~1×105 copies per cell (Figure 6B). These data,
therefore, reveal how hypoxia can alter the dominance of these
molecules in CTLs.September 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL ProteomeAdditionally, hypoxia caused CTLs to increase the
abundance of multiple molecules involved in cell adhesion
and trafficking including integrins, galectin-3 and many
chemokine receptors including CCR5, CXCR6 and CXCR4
(Figure 6C). These latter chemokine receptors are known to
control T cell trafficking into tumours and sites of inflammation.Frontiers in Immunology | www.frontiersin.org 12These changes support a model that hypoxia will promote T cell
recruitment and retention to sites of inflammation rather than
localisation in lymphoid tissues. However, we found that
hypoxia increased the abundance of CD62L in CTLs
(Supplementary Table S1). Previous studies have shown that





FIGURE 5 | The consequences of hypoxia on proteins involved in CTL cytolytic function. (A) Volcano plot showing the protein copy number ratio in CTLs subjected
to 24 hours of hypoxia (1% O2) compared to CTLs maintained in normoxia (18% O2) with granzymes and perforin highlighted in red and annotated. (B) Schematic
representation of secretory lysosomes showing cytolytic molecules and proteins required for degranulation. Average copy numbers for three biological replicates of
CTLs maintained in normoxia or subjected to 24 hours of hypoxia are annotated alongside, with * indicating the proteins that increase significantly in abundance in
hypoxia. (C, D) Copy numbers estimated from the proteomic data for IL-10 and IL-24. (E–G) CTLs were maintained in normoxia or subjected to hypoxia for 24
hours. Cytokine released by the CTLs was measured over a 4 hour period in normoxia or hypoxia. In (E) IL-10 was measured in unstimulated CTLs, and IFNg
(F) and TNFa (G) were measured in unstimulated cells and cells stimulated with the gp33 peptide. Data in (A, C–G) show three biological replicates. Data in
(B) show average values from three biological replicates. In bar charts, data points from each biological replicates are shown and colour matched, the bar shows the
mean and the error bars show standard deviation. P values were calculated using a two-tailed paired t-test. Non-significant changes are marked NS.September 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL Proteomethe adhesion molecule, CD62L (28) and repress the ability of
CTL to traffic into secondary lymphoid tissues (26, 28). It is,
therefore, possible that an increase in CD62L in response to
hypoxia may be triggered by pathways other than increasedFrontiers in Immunology | www.frontiersin.org 13transcription, such as inhibited shedding of the ectodomain
(66). Indeed, as elevated CD62L has been associated with
increased ability of CD8+ T cells to infiltrate sites of infection






FIGURE 6 | Changes to plasma membrane receptors induced by hypoxia. (A) Volcano plot showing the protein copy number ratio in CTLs subjected to 24 hours of
hypoxia (1% O2) compared to CTLs maintained in normoxia (18% O2) with co-stimulatory and inhibitory checkpoint molecules annotated and highlighted in red.
(B) Schematic representation of the T cell receptor (TCR) and selected co-stimulatory and inhibitory checkpoint molecules. Average copy numbers for three
biological replicates of CTLs maintained in normoxia or subjected to 24 hours of hypoxia are annotated alongside, with * indicating the proteins that increase
significantly in abundance in hypoxia. (C) Volcano plot showing the protein copy number ratio in CTLs subjected to 24 hours of hypoxia (1% O2) compared to CTLs
maintained in normoxia (18% O2) with selected adhesion molecules and chemokine receptors highlighted in red. (D–G) Copy numbers estimated from the proteomic
data for the indicated proteins. (H) Schematic representation of the IL-2 receptor and JAK-STAT5 signalling pathway. Average copy numbers for three biological
replicates of CTLs maintained in normoxia or subjected to 24 hours of hypoxia are annotated alongside. Data in (A, C–G) show three biological replicates. Data in (B,
H) show average values from three biological replicates. In bar charts, data points from each biological replicate are shown, and are colour matched, the bar shows
the mean and the error bars show standard deviation. P values were calculated using a two-tailed paired t-test.September 2021 | Volume 12 | Article 712402
Ross et al. Hypoxia Reconfigures the CTL Proteomeupregulation of CD62L may also be beneficial for allowing CD8+
T cells to enter diseased tissues.
We also identified that hypoxia increased the abundance of a
number of cytokine receptors expressed by CTLs, which may
then confer sensitivity to different immune stimuli in their
environment. We observed an increase in the IL-7 receptor
alpha chain (IL-7Ra) (Figure 6D). Interestingly the beta
subunit of the IL-10 receptor (IL10RB) was reproducibly
increased in abundance in hypoxic CTLs, although this
increase was not statistically significant (Figure 6E), Notably,
the tumour necrosis factor receptor superfamily member 1B
(TNFRSF1B also known as tumour necrosis factor receptor 2,
TNFR2) increased from ~25,000 copies per cell in normoxia
to ~100,000 copies per cell in hypoxia (Figure 6F). Hypoxia also
caused CTLs to increase the abundance of the IL-2 receptor alpha
chain (IL-2Ra) (Figures 6G, H). However, the rate limiting
components of the IL-2 receptor complex, the IL-2R beta chain
and the common gamma chain did not show substantial or
reproducible changes in abundance in response to hypoxia. Nor
were there any changes in expression of the tyrosine kinases JAK1
and JAK3, that mediate signalling by the IL-2 receptor (Figure 6H).
Therefore, the impact of hypoxia on the expression of cytokine
receptors, was also highly selective.DISCUSSION
The impact of hypoxia, and activation of oxygen-sensing
signalling pathways, has been reported to both stimulate (23,Frontiers in Immunology | www.frontiersin.org 1426–28, 32, 33) and inhibit (69) CD8+ T cell functions. Here, we
provide a quantitative and comprehensive understanding of the
impact of hypoxia on the proteome of differentiated CTLs. Our
data highlight that hypoxic environments may stimulate some
functions of CTL, such as increasing the abundance of cytolytic
molecules, but these changes are accompanied by a parallel
increase in the abundance of inhibitory checkpoint molecules
and the cytokine IL-10, and a decreased ability to produce pro-
inflammatory cytokines in response to antigen-receptor
stimulation (Figure 7).
These data are consistent with oxygen-dependent signalling
pathways targeting the activity of CTLs towards cell-mediated
killing whilst restricting excess tissue damage. Inhibitory receptors
such as CTLA-4, PD-1 and LAG3 are not expressed by naïve T
cells but are upregulated in activated T cells (70–72). The higher
abundances of inhibitory checkpoint molecules, as well as the
upregulation of perforin and granzymes, is consistent with
hypoxic CTLs having an augmented cytolytic phenotype but
where the cells may be limited in their ability to attack healthy
cells. However, it is also possible that hypoxia may convert CTLs
to having a regulatory phenotype. For example, IL-10-producing
CD8+ effector T cells are associated with being protective during
an immune response (73, 74). Indeed, subsets of CD8+ Tregs are
characterised by the expression of markers including CD25,
CTLA-4 or PD-1 (75–78). Moreover, an increase in IL-10 could
further restrict the activity of cytolytic CTLs as IL-10 has been
shown to decrease their sensitivity to antigens (79).
A major novelty, and advantage, of our quantitative
proteomic data is that it provides information on the relative
abundance of different proteins that cannot be inferred fromFIGURE 7 | Overview of the impact of hypoxia on CTLs. Schematic representation of changes induced by hypoxia on CTLs, and their implications for regulating the
function of CTLs in different immune environments.September 2021 | Volume 12 | Article 712402
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cytometry or western blot. Therefore, although both co-
stimulatory and inhibitory checkpoint molecules are
upregulated in response to hypoxia, our data revealed that
LAG3 was the most abundant inhibitory checkpoint molecule,
and its substantial upregulation in response to hypoxia increased
its abundance greater than that of GITR and 4-1BB combined.
These changes in response to hypoxia could, therefore, shift the
balance of CTLs towards responding to inhibitory signals within
an immune environment. Consequently, the overall impact of
activation of hypoxia-induced signalling pathways in CD8+ T
cells may be dependent on the context, and other factors which
can regulate the activity of the T cells in the immune environment,
including immune and metabolic checkpoint molecules.
Another important and novel observation from this study was
that hypoxia can override IL-2-induced DNA-synthesis and
proliferation programmes. In the context of immune cells, it is
an intriguing possibility that oxygen levels within an immune
niche may play a role in limiting excessive proliferation.
Additionally, up-regulation of perforin in CTL may be an
important negative feedback control of their functions in
hypoxic environments. Mutations that cause perforin deficiency
in humans are associated with the disorder, Hemophagocytic
lymphohistiocytosis (HLH) (80). Rather than causing
immunodeficiency, loss of perforin causes systemic inflammation
during immune activation, often triggered by infection (80). This
inflammation, associated with excessive activation of CTLs and
macrophages and a cytokine storm, is thought to be caused by the
failure of CD8+ T cells to kill antigen-presenting dendritic cells
(81). Therefore, our data reinforce a role for hypoxia, and oxygen-
sensing signalling pathways, in controlling the balanced activity of
CTLs, limiting their clonal expansion and promoting activities that
may contribute to resolving an immune response.
Transcriptional programmes induced by HIF are likely to play a
major role in controlling gene expression and functional changes in
CTLs in response to hypoxia. Previous studies have shown that
activation of HIF1-induced transcriptional pathways via knockout
of PHD1/2/3 or VHL can augment the killing activities of CTLs,
stimulating glycolytic metabolism and the expression of granzyme
B and perforin and co-stimulatory molecules (27, 32, 33). Our data
are consistent with these findings. Approximately 70 proteins
increased in abundance in CTL in response to hypoxia were
decreased at the transcript level in HIF1b-deficient CTLs: this
included the transporters GLUT1, GLUT3 and SLC16A3;
glycolytic enzymes; perforin; granzymes C, D, E and G; 4-1BB
and ICOS; the IL-7 receptor alpha chain; IL-10; IL-24; Tim-3 and
PD-1; chemokine and adhesion molecules; and the glycosylases
ST6GAL1, GCNT1 and GALNT6 (28). Even so, some of these
changes in mRNA or protein abundance could be indirect from
HIF-mediated transcription. One important transcription factor in
immune cells is NFIL3, and its expression in CD8+ T cells is HIF-
dependent (28, 34). Interestingly, several proteins that increase in
hypoxia have been reported to depend on NFIL3 in T cells. This
includes Tim-3 (82), IL-10 (82, 83) and perforin (34).
Consequently, these data indicate that some changes in gene
expression that take place in hypoxic T cells may depend onNFIL3.Frontiers in Immunology | www.frontiersin.org 15Approximately 30% of the proteins increased in abundance in
hypoxia did not map to genes found to change in abundance in
the microarray analysis of HIF1b knockout CTLs. While this
could reflect differences in normalisation and statistical
approaches that reveal genes or proteins that are regulated, it is
also possible that up-to 270 proteins may be increased in CTLs in
response to hypoxia via HIF-independent mechanisms. This
could reflect regulation of protein stability through PHD
family members (39) or the ADO-controlled N-degron
pathway (44). Alternatively, changes to glucose metabolism
may contribute to differential expression of proteins in
response to hypoxia. For example, another novel observation
from our study is that several proteins involved in protein
glycosylations were increased in response to hypoxia.
Therefore, these changes may alter the abundance of post-
translational glycoslyations that control protein stability.
Additionally, changes to mitochondrial respiration during
hypoxia may be an important factor that influences gene
expression. We identified components of mitochondrial
complexes that were decreased in abundance in hypoxia, which
have the potential to block mitochondrial-dependent signalling
pathways. In CD4+ T cells, IFNg production has been shown to
be inhibited by loss of mitochondrial respiration (84). Therefore,
these changes could be a factor which contributes to the decrease
in IFNg production in response to antigen stimulation in hypoxic
CTLs compared to their normoxic counterparts.
This study provides an important resource quantifying
changes in the abundance of proteins that are relevant for
understanding how CTLs may function in hypoxic immune
environments (Figure 7). Our data demonstrate how hypoxia
may integrate with, and alter, cytokine and antigen-induced gene
expression programmes. Recently it has been shown that chronic
antigen stimulation in combination with hypoxia may promote
T cell exhaustion via exacerbating mitochondrial dysfunction in
tumour microenvironments (17, 85, 86). Although deficiency of
VHL and PHD1/2/3 may not fully mimic hypoxia, it is also
interesting to note that constitutive activation of the HIF-
transcriptional pathway alone may also have context-specific
phenotypes. For example, cell-intrinsic immunopathology was
only observed in VHL-deficient CD8+ T cells in response to
persistent antigen resulting from chronic infection, but not in
response to acute infections or antigens associated with tumours,
where constitutive HIF expression was beneficial (27). As
hypoxia is a feature of immune responses in which pathogens
can be cleared from the body and diseases which are exacerbated
by immune cell dysfunction, it will be important to know more
about the signals that may alter the balance of oxygen-sensing
pathways within a hypoxic immune environment.DATA AVAILABILITY STATEMENT
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